Literature DB >> 21993269

Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques.

Nafis Shafizadeh1, Sanjay Kakar.   

Abstract

There is considerable overlap in morphologic features in well-differentiated hepatocellular lesions necessitating the use of immunohistochemistry and other techniques for diagnosis. Map-like pattern with glutamine synthetase in focal nodular hyperplasia and cytoplasmic staining with serum amyloid associated protein in inflammatory hepatocellular adenoma (HA) are useful for this distinction. The distinction of well-differentiated hepatocellular carcinoma (HCC) and HA in noncirrhotic liver is facilitated by demonstrating glypican-3 and cytogenetic changes like gains of chromosomes 1 and 8. Nuclear staining with β-catenin and/or diffuse staining with glutamine synthetase strongly favors well-differentiated HCC or HA with high risk for HCC. In a cirrhotic liver, separation of early HCC from high-grade dysplastic nodule requires identification of stromal invasion, which can be highlighted by absence of keratin 7-positive ductular reaction. Combined use of heat shock protein 70, glutamine synthetase, and glypican-3 can be useful as positivity for 2 or more of these markers has shown high specificity for HCC in early studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21993269     DOI: 10.1097/PAP.0b013e318234abb4

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  12 in total

Review 1.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

2.  Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma.

Authors:  N E El-Bassiouni; M M F Nosseir; M E Madkour; M M K Zoheiry; I W Bekheit; R A Ibrahim; I M Ibrahim; A E El Bassiouny
Journal:  Mol Biol Rep       Date:  2012-02-09       Impact factor: 2.316

Review 3.  Differential diagnosis and management of liver tumors in infants.

Authors:  Israel Fernandez-Pineda; Rosa Cabello-Laureano
Journal:  World J Hepatol       Date:  2014-07-27

4.  The Applicability of a Human Immunohistochemical Panel to Mouse Models of Hepatocellular Neoplasia.

Authors:  Kenneth J Salleng; Frank L Revetta; Natasha G Deane; M Kay Washington
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

5.  Beta-Catenin Staining of Hepatocellular Adenomas.

Authors:  Monica T Garcia-Buitrago
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-12

6.  Heterogeneity of antigenic constellation in human hepatocellular carcinoma.

Authors:  Mihai Ceausu; Bogdan Socea; Dragos Serban; Cătălin Gabriel Smarandache; Dragoş Predescu; Nicolae Bacalbaşa; Iulian Slavu; Adrian Tulin; Lucian Alecu; Zenaida Ceauşu
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

Review 7.  Histopathology of hepatocellular carcinoma.

Authors:  Manuel Schlageter; Luigi Maria Terracciano; Salvatore D'Angelo; Paolo Sorrentino
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

8.  Ductular reaction, cytokeratin 7 positivity, and gamma-glutamyl transferase in multistage hepatocarcinogenesis in rats.

Authors:  Andrea Janz Moreira; Graziella Ramos Rodrigues; Silvia Bona; Leila Xavier Sinigaglia Fratta; Giovana Regina Weber; Jaqueline Nascimento Picada; Jorge Luiz Dos Santos; Carlos Thadeu Cerski; Claudio Augusto Marroni; Norma Possa Marroni
Journal:  Protoplasma       Date:  2016-08-15       Impact factor: 3.356

9.  Signal Transducer and Activator of Transcription 3 for the Differentiation of Hepatocellular Carcinoma from Cirrhosis.

Authors:  Yan-Ping Li; Wen-Ze Wang; Xue-Qi Chen; Ling-Bo Li; Zhi-Yong Liang; Kun Ru; Jing-Nan Li
Journal:  Chin Med J (Engl)       Date:  2017-11-20       Impact factor: 2.628

10.  Comparative histomorphological review of rat and human hepatocellular proliferative lesions.

Authors:  Bob Thoolen; Fiebo J W Ten Kate; Paul J van Diest; David E Malarkey; Susan A Elmore; Robert R Maronpot
Journal:  J Toxicol Pathol       Date:  2012-10-01       Impact factor: 1.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.